Drawing for AUVIMSEO

USPTO serial 99934148

AUVIMSEO

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
REYNOLDS,DYLAN M
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 686 means your mark is published in the USPTO Official Gazette and in the 30-day opposition period. If no opposition is filed, prosecution typically continues toward registration or a Notice of Allowance. Monitor the opposition window. After it closes, watch for Notice of Allowance (intent-to-use) or registration (use-based).

Status 686: Status 686 means your mark is published in the USPTO Official Gazette and in the 30-day opposition period. If no opposition is filed, prosecution typically continues toward registration or a Notice of Allowance.

Need help with AUVIMSEO?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Xiomara Triana

Xiomara Triana Bristol-Myers Squibb CompanyP.O. Box 4000Trademark Dept., Mailstop D.4243Princeton, NJ 08543

Goods and services

ClassDescriptionStatusFirst use
005Antivirals; Antibodies for medical purposes; Anticoagulants; Stem cells for medical purposes; Radiopharmaceutical preparations for the treatment of cancer and solid tumors; Diagnostic radiopharmaceutical preparations; Diagnostic preparations for medical purposes; Pharmaceutical preparations for the treatment and prevention of obesity, cardiovascular diseases, central nervous system diseases, metabolic disorders, stroke, cancer, inflammatory diseases, respiratory diseases, infectious diseases, autoimmune diseases, solid organ transplant rejection, autoinflammatory diseases, blood diseases, multiple sclerosis, ulcerative colitis, cystic fibrosis, arthritis, Alzheimer’s disease, autism spectrum disorder, and musculoskeletal and skin diseases; Biological preparations for the treatment of cancerACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 27, 2026NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Oct 27, 2026PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 21, 2026NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Sep 28, 2026CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 25, 2026DOCKASSIGNED TO EXAMINER—
Jul 10, 2026MAFRAPPLICATION FILING RECEIPT MAILED—
Jul 10, 2026NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jul 10, 2026NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance